Author/Authors :
Joël Robichaud، نويسنده , , Christopher I. Bayly، نويسنده , , W. Cameron Black، نويسنده , , Sylvie Desmarais، نويسنده , , Serge Léger، نويسنده , , Frédéric Massé، نويسنده , , Daniel J. McKay، نويسنده , , Renata M. Oballa، نويسنده , , Julie Pâquet، نويسنده , , M. David Percival، نويسنده , , Jean François Truchon، نويسنده , , Gregg Wesolowski، نويسنده , , Sheldon N. Crane، نويسنده ,
Abstract :
Further SAR study around the central 1,2-disubstituted phenyl of the previously disclosed Cat K inhibitor (−)-1 has demonstrated that the solvent exposed P2–P3 linker can be replaced by various 5- or 6-membered heteroaromatic rings. While some potency loss was observed in the 6-membered heteroaromatic series (IC50 = 1 nM for pyridine-linked 4 vs 0.5 nM for phenyl-linked (±)-1), several inhibitors showed a significantly decreased shift in the bone resorption functional assay (10-fold for pyridine 4 vs 53-fold for (−)-1). Though this shift was not reduced in the 5-membered heteroaromatic series, potency against Cat K was significantly improved for thiazole 9 (IC50 = 0.2 nM) as was the pharmacokinetic profile of N-methyl pyrazole 10 over our lead compound (−)-1.
Keywords :
athepsin K , osteoporosis , inhibitor , Cyclohexanecarboxamide , Nitrile warhead , modeling , bone resorption